Inventor
HARDCASTLE IAN ROBERT
GB15 patents
⚠️ This page may combine multiple inventors who share the name “HARDCASTLE IAN ROBERT”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ASTEX THERAPEUTICS LTD
5 patentsUS10544132B2Jan 28, 2020
Isoindolinone inhibitors of the MDM2-p53 interaction having anticancer activity
ASTEX THERAPEUTICS LTD10 citations82
US10526311B2Jan 7, 2020
Isoindolinone inhibitors of the MDM2-P53 interaction having anticancer activity
ASTEX THERAPEUTICS LTD6 citations82
US11261171B1Mar 1, 2022
Isoindolinone inhibitors of the MDM2-P53 interaction having anticancer activity
ASTEX THERAPEUTICS LTD2 citations71
US10981898B2Apr 20, 2021
Isoindolinone inhibitors of the MDM2-p53 interaction having anticancer activity
ASTEX THERAPEUTICS LTD4 citations71
US12071429B2Aug 27, 2024
Isoindolinone inhibitors of the MDM2-P53 interaction having anticancer activity
ASTEX THERAPEUTICS LTD0 citations60
CANCER REC TECH LTD
4 patentsUS9358222B2Jun 7, 2016
Therapeutic agents
CANCER REC TECH LTD9 citations81
US7674823B2Mar 9, 2010
DNA-PK inhibitors
CANCER REC TECH LTD3 citations60
US7226918B2Jun 5, 2007
DNA-PK inhibitors
CANCER REC TECH LTD4 citations60
US7105518B2Sep 12, 2006
Thiopyrane-4-ones as DNA protein kinase inhibitors
CANCER REC TECH LTD5 citations60